Stock listing
BIVA:ANAB AnaptysBio, Inc. Acciones
Mexican listing (BIVA) of AnaptysBio, Inc. · home listing NASDAQ:ANAB
Follow AnaptysBio, Inc. into a list and get an email when it puts out news.
Home listing price · NASDAQ:ANAB
$48.28 USD -0.36 (-0.7%)
Close on Oct 30, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:ANAB
- Day range
- $47.89 – $48.97 USDOct 30, 2026
- Volume
- 293,615 sharesOct 30, 2026
- Market cap
- $1.44B USDAt the close on Oct 30, 2026 · price × 29.90M shares outstanding
- 52-week range
- $20.18 – $72.36 USDLowest and highest trades, Oct 31, 2025 – Oct 30, 2026
- Traded on an average day
- $25.95M USDMedian day 417,700 shares · last 3 months, Jul 30, 2026 – Oct 30, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:ANAB · Home | $48.28 USD | -0.36 (-0.7%) | 293,615 | $48.45 | $48.97 | $47.89 | $48.64 | Close on Oct 30, 2026 |
| LSE:0HFQ | $49.17 USD | +2.07 (+4.4%) | 482 | $50.00 | $50.09 | $49.17 | $47.10 | Close on Oct 27, 2026 |
| Frankfurt:AN6 | €42.78 EUR | -1.32 (-3.0%) | — | €43.07 | €43.27 | €42.42 | €44.10 | Close on Oct 30, 2026 |
Daily closes
Last 3 months, Jul 30, 2026 – Oct 30, 2026 · NASDAQ:ANAB · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $48.28 | -0.36 | -0.7% | $48.45 | $48.97 | $47.89 | 293,615 | |
| $48.64 | -1.86 | -3.7% | $50.61 | $51.22 | $48.33 | 414,328 | |
| $50.50 | +0.87 | +1.8% | $49.76 | $50.55 | $49.00 | 306,131 | |
| $49.63 | +0.86 | +1.8% | $49.24 | $50.02 | $48.70 | 349,577 | |
| $48.77 | +0.04 | +0.1% | $48.97 | $49.62 | $47.98 | 417,135 | |
| $48.73 | +0.63 | +1.3% | $48.19 | $48.89 | $47.05 | 468,090 | |
| $48.10 | +0.16 | +0.3% | $47.65 | $48.51 | $46.83 | 254,904 | |
| $47.94 | +2.51 | +5.5% | $45.48 | $48.48 | $45.48 | 664,422 | |
| $45.43 | -3.81 | -7.7% | $49.57 | $51.85 | $44.02 | 1,201,785 | |
| $49.24 | +2.63 | +5.6% | $47.33 | $49.88 | $47.33 | 468,354 | |
| $46.61 | -2.10 | -4.3% | $48.56 | $48.56 | $46.46 | 413,600 | |
| $48.71 | +2.04 | +4.4% | $47.43 | $48.83 | $46.93 | 416,300 | |
| $46.67 | +1.08 | +2.4% | $45.25 | $47.24 | $45.00 | 494,100 | |
| $45.59 | -0.45 | -1.0% | $45.53 | $46.13 | $45.16 | 416,500 | |
| $46.04 | +0.09 | +0.2% | $46.16 | $46.78 | $45.99 | 371,600 | |
| $45.95 | -0.26 | -0.6% | $46.11 | $47.19 | $45.81 | 495,200 | |
| $46.21 | +0.56 | +1.2% | $45.36 | $46.77 | $44.74 | 554,200 | |
| $45.65 | -2.24 | -4.7% | $47.00 | $47.39 | $45.62 | 766,500 | |
| $47.89 | -1.31 | -2.7% | $49.41 | $49.41 | $47.35 | 627,100 | |
| $49.20 | +0.67 | +1.4% | $48.53 | $49.84 | $47.52 | 595,500 | |
| $48.53 | -0.10 | -0.2% | $48.97 | $49.83 | $48.28 | 441,100 | |
| $48.63 | -1.63 | -3.2% | $49.94 | $50.98 | $48.13 | 512,300 | |
| $50.26 | -0.11 | -0.2% | $50.13 | $52.02 | $49.39 | 1,430,100 | |
| $50.37 | -0.43 | -0.8% | $50.44 | $50.90 | $49.46 | 677,600 | |
| $50.80 | -0.20 | -0.4% | $51.00 | $51.65 | $50.50 | 412,600 | |
| $51.00 | -0.70 | -1.4% | $52.38 | $52.38 | $50.80 | 437,700 | |
| $51.70 | +0.93 | +1.8% | $50.59 | $52.16 | $50.35 | 417,800 | |
| $50.77 | -3.15 | -5.8% | $53.55 | $53.93 | $49.45 | 779,600 | |
| $53.92 | -1.00 | -1.8% | $55.07 | $56.04 | $50.61 | 755,700 | |
| $54.92 | -0.28 | -0.5% | $56.00 | $56.00 | $54.09 | 524,400 | |
| $55.20 | +0.14 | +0.3% | $55.76 | $55.77 | $53.71 | 868,800 | |
| $55.06 | +0.75 | +1.4% | $55.09 | $55.79 | $54.49 | 439,600 | |
| $54.31 | -0.37 | -0.7% | $54.44 | $54.80 | $53.62 | 394,100 | |
| $54.68 | +0.57 | +1.1% | $54.28 | $55.32 | $53.22 | 351,800 | |
| $54.11 | +0.24 | +0.4% | $54.58 | $55.70 | $54.00 | 436,800 | |
| $53.87 | -1.29 | -2.3% | $55.43 | $56.32 | $53.75 | 336,200 | |
| $55.16 | -0.54 | -1.0% | $55.43 | $56.43 | $54.31 | 300,100 | |
| $55.70 | -0.90 | -1.6% | $55.59 | $57.89 | $55.25 | 295,700 | |
| $56.60 | -0.20 | -0.4% | $55.48 | $58.17 | $54.79 | 1,036,100 | |
| $56.80 | -0.66 | -1.1% | $56.84 | $58.77 | $56.10 | 1,061,900 | |
| $57.46 | +1.62 | +2.9% | $56.33 | $57.77 | $55.00 | 363,800 | |
| $55.84 | +0.56 | +1.0% | $56.13 | $57.90 | $54.66 | 421,700 | |
| $55.28 | -1.75 | -3.1% | $56.82 | $58.09 | $54.84 | 773,900 | |
| $57.03 | +0.75 | +1.3% | $55.83 | $57.22 | $55.00 | 332,100 | |
| $56.28 | -1.01 | -1.8% | $57.24 | $57.24 | $55.38 | 358,300 | |
| $57.29 | -0.71 | -1.2% | $58.03 | $58.43 | $57.10 | 533,700 | |
| $58.00 | -0.37 | -0.6% | $58.27 | $58.86 | $57.37 | 210,300 | |
| $58.37 | -0.07 | -0.1% | $58.09 | $58.99 | $56.81 | 341,835 | |
| $58.44 | +0.70 | +1.2% | $56.96 | $59.07 | $55.57 | 627,045 | |
| $57.74 | +1.05 | +1.9% | $57.23 | $58.78 | $56.62 | 318,400 | |
| $56.69 | -2.57 | -4.3% | $58.52 | $59.69 | $56.33 | 389,300 | |
| $59.26 | +0.27 | +0.5% | $60.31 | $60.31 | $58.43 | 258,700 | |
| $58.99 | -0.70 | -1.2% | $58.90 | $60.02 | $58.16 | 260,400 | |
| $59.69 | +1.22 | +2.1% | $57.78 | $59.89 | $57.49 | 255,700 | |
| $58.47 | +2.45 | +4.4% | $56.00 | $58.54 | $55.30 | 330,900 | |
| $56.02 | -0.96 | -1.7% | $57.07 | $57.65 | $55.60 | 270,900 | |
| $56.98 | -0.89 | -1.5% | $57.99 | $58.11 | $56.64 | 381,700 | |
| $57.87 | +2.40 | +4.3% | $56.79 | $59.00 | $56.41 | 372,049 | |
| $55.47 | -1.14 | -2.0% | $56.56 | $58.86 | $55.32 | 419,583 | |
| $56.61 | +1.84 | +3.4% | $55.20 | $57.38 | $55.13 | 546,700 | |
| $54.77 | -0.22 | -0.4% | $55.28 | $56.07 | $53.45 | 288,800 | |
| $54.99 | -0.14 | -0.3% | $55.42 | $56.65 | $54.33 | 316,600 | |
| $55.13 | +1.47 | +2.7% | $55.14 | $55.48 | $53.41 | 417,600 | |
| $53.66 | +0.30 | +0.6% | $53.40 | $53.98 | $51.85 | 433,700 | |
| $53.36 | -1.68 | -3.1% | $54.10 | $54.52 | $52.23 | 451,400 | |
| $55.04 | +2.90 | +5.6% | $52.98 | $55.29 | $51.92 | 1,069,600 |
- Ticker
- BIVA:ANAB
- Asset type
- Stock
- Exchange
- BIVA
- Currency
- MXN
What changed lately
Latest news release · Oct 19, 2026
Jemperli (dostarlimab) Approved in the U.S. as First and Only Immunotherapy for Adults with MSI-H/dMMR Locally Advanced Rectal Cancer
Latest deck · September 2026
Investor Presentation (September 2026)
Investor deck · 10 slides
Latest news
Jemperli (dostarlimab) Approved in the U.S. as First and Only Immunotherapy for Adults with MSI-H/dMMR Locally Advanced Rectal Cancer
Oct 19, 2026
Closed $49.24 (+5.6%) on Oct 19, 2026
Annual Transition Report (Form 10-KT)
Sep 21, 2026
Closed $53.92 (-1.8%) on Sep 22, 2026
Anaptys Announces Participation at the H.C. Wainwright 28th Annual Global Investment Conference
Sep 1, 2026
Closed $55.84 (+1.0%) on Sep 2, 2026
Anaptys Announces First Quarter 2026 Financial Results and Provides Business Update
May 12, 2026
Closed $62.69 (-4.4%) on May 13, 2026
Anaptys Appoints Chris Murphy as Chief Financial Officer and Owen Hughes to Board of Directors
May 11, 2026
Closed $67.92 (-2.0%) on May 11, 2026
Anaptys to Participate at the H.C. Wainwright 2nd Annual Royalty Company Virtual Conference
May 4, 2026
Closed $69.28 (-0.7%) on May 5, 2026
Vanda Pharmaceuticals announces the publication of "Efficacy and Safety of Imsidolimab for Generalized Pustular Psoriasis" in NEJM Evidence
Apr 28, 2026
Closed $62.34 (-5.7%) on Apr 29, 2026
Issued by another party
Delaware Chancery Court Rules in Favor of Anaptys by Dismissing Tesaro’s Anticipatory Breach Claim
Apr 24, 2026
Closed $58.88 (+14.8%) on Apr 24, 2026
Anaptys Completes Separation of First Tracks Biotherapeutics and Now Exclusively Manages GSK and Vanda Financial Collaborations
Apr 20, 2026
Closed $50.95 (+13.2%) on Apr 20, 2026
First Tracks Biotherapeutics, the Planned Spin-Off of Anaptys, Secures Commitments of $145 Million in Private Placement
Mar 27, 2026
Closed $38.27 (-11.7%) on Mar 27, 2026
Decks
Investor Presentation (September 2026)
Investor deck · 10 slides · September 2026
Investor Presentation (March 2026)
Investor deck · 66 slides · Mar 3, 2026
Investor Presentation (January 2026)
Investor deck · 65 slides · Jan 9, 2026
Investor Presentation (November 2025)
Investor deck · 67 slides · Nov 10, 2025
AnaptysBio, Inc. on 6ix
- News releases
- 23 in the last 12 months · 121 in all · newest Oct 19, 2026 · oldest 2019
- Decks
- 30 decks · latest September 2026
Where AnaptysBio, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:ANAB · Home listing | NASDAQ | United States | USD |
| gettex:AN6 | gettex | Germany | EUR |
| Lang & Schwarz:A2AJ8C | Lang & Schwarz | Germany | EUR |
| LS Exchange:A2AJ8C | LS Exchange | Germany | EUR |
| BMV:ANAB | BMV | Mexico | MXN |
| LSE:0HFQ | LSE | United Kingdom | USD |
| Tradegate:AN6 | Tradegate | Germany | EUR |
| BOATS:ANAB | BOATS | United States | USD |
| BIVA:ANAB · This page | BIVA | Mexico | MXN |
| Frankfurt:AN6 | Frankfurt | Germany | EUR |
| Dusseldorf:AN6 | Dusseldorf | Germany | EUR |
| Munich:AN6 | Munich | Germany | EUR |
| Stuttgart:AN6 | Stuttgart | Germany | EUR |
Log in to ask 6ix AI your own questions about AnaptysBio, Inc.